| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/05/1995 | WO1995000550A1 Aspb28 insulin crystals |
| 01/05/1995 | WO1995000549A1 Treatment of diabetes using phosphorylated insulin |
| 01/05/1995 | WO1995000547A1 Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type |
| 01/05/1995 | WO1995000546A1 Endothelin-antagonizing peptide |
| 01/05/1995 | WO1995000545A1 Synthetic peptides for the detection of antibodies against the virus of hepatitis c in the serum of infected persons |
| 01/05/1995 | WO1995000544A1 Method and composition for treating thrombosis |
| 01/05/1995 | WO1995000543A1 Anti-inflammatory peptides |
| 01/05/1995 | WO1995000541A1 Factor vii-derived peptides |
| 01/05/1995 | WO1995000540A1 Synthetic carrier and immunogen |
| 01/05/1995 | WO1995000538A1 Peptides derived from human interleukin-2 for use in medicine |
| 01/05/1995 | WO1995000534A1 Alpha-helix mimetics and methods relating thereto |
| 01/05/1995 | WO1995000178A1 Pore-forming and superantigen encoding toxin cassettes for gene therapy |
| 01/05/1995 | WO1995000172A1 Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof |
| 01/05/1995 | WO1995000166A1 Pharmaceutical compositions for stimulating reconstruction of hemopoietic microenvironment |
| 01/05/1995 | WO1995000164A1 PEPTIDES AND ANTIBODIES TO HUMAN C5a RECEPTOR AND METHOD OF TREATMENT |
| 01/05/1995 | WO1995000163A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | WO1995000162A1 Site specific synthesis of conjugated peptides |
| 01/05/1995 | WO1995000161A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | WO1995000160A1 Programmed cell death genes and proteins |
| 01/05/1995 | WO1995000159A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 01/05/1995 | WO1995000156A1 Compositions and methods for treatment and prevention of retinal dysfunctions |
| 01/05/1995 | WO1994026922A3 Methods and compositions relating to sterol regulatory element binding proteins |
| 01/05/1995 | WO1994024160A3 Erythropoietin muteins with enhanced activity |
| 01/05/1995 | WO1994023049A3 The introduction and expression of large genomic sequences in transgenic animals |
| 01/05/1995 | WO1994023041A3 Method for selective inactivation of viral replication |
| 01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
| 01/05/1995 | WO1994018324A3 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 01/05/1995 | WO1994017099A3 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 01/05/1995 | WO1994010288A3 Medium-chain thioesterases in plants |
| 01/05/1995 | DE4405841C1 Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals |
| 01/05/1995 | DE4318186A1 Retrovirus from HIV group and use thereof |
| 01/05/1995 | CA2166124A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
| 01/05/1995 | CA2166104A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
| 01/05/1995 | CA2166078A1 Vectors for genetically engineered cells that produce insulin in response to glucose |
| 01/05/1995 | CA2165951A1 Treatment of diabetes using phosphorylated insulin |
| 01/05/1995 | CA2165797A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | CA2165786A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | CA2165777A1 Programmed cell death genes and proteins |
| 01/05/1995 | CA2165679A1 Anti-sickling hemoglobin |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2165461A1 Compositions and diagnostic methods using monoclonal antibodies against cd44v6 |
| 01/05/1995 | CA2165332A1 Method and composition for treating thrombosis |
| 01/05/1995 | CA2165202A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use |
| 01/05/1995 | CA2165200A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2165053A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 01/05/1995 | CA2164966A1 Compositions and methods for anti-addictive narcotic analgesis activity screening and treatments |
| 01/05/1995 | CA2164728A1 Processes for diagnosing and analysing tumours |
| 01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
| 01/05/1995 | CA2164422A1 Factor vii-derived peptides |
| 01/05/1995 | CA2162485A1 Toxin gene from xenorhabdus nematophilus |
| 01/05/1995 | CA2142985A1 Endothelin-antagonizing peptide |
| 01/05/1995 | CA2142604A1 Alpha-helix mimetics and methods relating thereto |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632055A1 An anticoagulant substance obtained from urine |
| 01/04/1995 | EP0632054A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 01/04/1995 | EP0632053A2 Cyclic adhesion inhibitors |
| 01/04/1995 | EP0632052A1 Endothelin antagonistic peptides |
| 01/04/1995 | EP0631727A1 Lipase inhibitor derived from a defatted rice germ |
| 01/04/1995 | EP0631636A1 Exchangeable template reaction |
| 01/04/1995 | EP0631630A1 Control of male fertility using externally inducible promoter sequences |
| 01/04/1995 | EP0631629A1 Fungus-responsive chimaeric gene |
| 01/04/1995 | EP0631627A1 A method for production of proteins in yeast |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631617A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 01/04/1995 | EP0631597A1 Super porous polysaccharide gels |
| 01/04/1995 | EP0631586A1 Amino procollagen 1(i) peptides |
| 01/04/1995 | EP0631585A1 Protein production |
| 01/04/1995 | EP0631584A1 Cancer diagnosis and therapy |
| 01/04/1995 | EP0631506A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 01/04/1995 | EP0631502A1 Lymphocyte activity regulation by hla peptides |
| 01/04/1995 | EP0631501A1 Glycosylation-mediated inhibition of factor x |
| 01/04/1995 | EP0567576B1 Treatment of neoplastic disease with interleukin-10 |
| 01/04/1995 | EP0514405B1 Strain ral-4, useful for production of small proteins and peptides |
| 01/04/1995 | EP0463072B1 Novel insulin compounds |
| 01/04/1995 | EP0435946B1 Methods for modifying the binding of cell adhesion receptors |
| 01/04/1995 | EP0404935B1 Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1 |
| 01/04/1995 | EP0201588B1 Assay for detecting infection by human t-cell lymphotrophic virus |
| 01/04/1995 | CN1096962A Dynorphin a suppression of natural killer cell activity |
| 01/04/1995 | CN1027271C Method for preparation of polypeptide with nor-state and nor-cyclostatine |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378822 Nucleic acids encoding murine and human Ah receptors |
| 01/03/1995 | US5378820 Gene encoding cytadhesin protein of mycoplasma gallisepticum and its use |
| 01/03/1995 | US5378819 Nucleic acid or DNA for genetic engineering |
| 01/03/1995 | US5378816 Methods for high purity chromatographic separation of proteins having EGF-like binding domains |
| 01/03/1995 | US5378814 Hepatitis delta viral polypeptides |
| 01/03/1995 | US5378812 Human antibodies which specifically bind to lipopolysaccharide determinants of some pseudomonas serotypes and inhibit these bacteria, for prevention and treatment of infections |
| 01/03/1995 | US5378811 Pure C3b inactivator and a process for producing said protein |
| 01/03/1995 | US5378810 Mutant Smg p21 protein with GTP binding activity |
| 01/03/1995 | US5378809 Polynucleotides and substrate for the epidermal growth factor receptor kinase (eps8) |
| 01/03/1995 | US5378808 Isolated DNA sequence; anemia; genetic engineering |
| 01/03/1995 | US5378806 Genetic engineering |
| 01/03/1995 | US5378805 Immunoreactive HTLV-I/II ENV and POL peptides |
| 01/03/1995 | US5378625 Bacillus thuringiensis cryIIIC, (b) protein toxic to coleopteran insects |
| 01/03/1995 | US5378620 Streptolysin O derivatives |
| 01/03/1995 | US5378619 Promoter from figwort mosaic virus |
| 01/03/1995 | US5378614 Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast |
| 01/03/1995 | US5378613 Method for increased expression of low molecular weight recombinant polypeptides |
| 01/03/1995 | US5378612 Nonionic surfactant, cyclodextrin |
| 01/03/1995 | US5378603 Cholesterol regulating |